The detection of cell-free fetal DNA from maternal plasma and serum by Dennis Lo and colleagues at Oxford University, UK, opened an exciting route for the noninvasive determination of fetal genetic traits (1 ). It has proved very effective for identifying fetal genetic loci completely absent from the maternal genome, such as those on the Y chromosome or the RHD (Rh blood group, D antigen) gene ...

BACKGROUND Noninvasive prenatal diagnosis with cell-free DNA in maternal plasma is challenging because only a small portion of the DNA sample is derived from the fetus. A few previous studies provided size-range estimates of maternal and fetal DNA, but direct measurement of the size distributions is difficult because of the small quantity of cell-free DNA. METHODS We used high-throughput pair...

Background : Prenatal paternity test is mostly performed by using Amniocentesis or Chorionic Villus Sampling (CVS) methods. However, these methods require invasive procedures, which are potentially harmful for both the mother and fetus. Currently, invention of Cell-Free Fetal DNA (cffDNA) has offered opportunity performing prenatal non-invasively. Materials Methods This study a cross sectional ...

in previous years, identification of fetal cells in maternal blood circulation has caused a new revolution in non-invasive method of prenatal diagnosis. low number of fetal cells in maternal blood and long-term survival after pregnancy limited the use of fetal cells in diagnostic and clinical applications. with the discovery of cell-free fetal dna (cffdna) in plasma of pregnant women, access to...

OBJECTIVE Among the pitfalls of using cell-free fetal DNA in plasma for prenatal diagnosis is quality of the recovered DNA fragments and concomitant presence of maternal DNA (>95%). Our objective is to provide alternative methods for achieving enrichment and high-quality fetal DNA from plasma. METHODS Cell-free DNA from 31 pregnant women and 18 controls (10 males and 8 females) were size sepa...

The existence of cell free DNA in the human circulatory system has been known since the 1950s, however, intensive research in this area has been conducted for the last ten years. This review paper brings a short overview of the existing literature concerning the cell free DNA research in various clinical fields and pathological states and considers the application possibilities of this new anal...

Cell free fetal DNA (cff DNA) is apoptotic that shed from placenta and flows in maternal blood. This can be used as an indicative biomarker to rule out pregnancy associated complications. The objective of this study investigate the correlation concentration cff with intrauterine deaths. RHD gene (Rh blood group, D antigen) was marker for confirmation GAPDH (Glyceraldehyde-3-phosphate dehydrogen...

BACKGROUND Second-trimester cell-free fetal DNA (studied only in pregnancies with male fetuses) is higher in maternal serum samples from women carrying Down syndrome fetuses than in unaffected pregnancies. In this study we evaluated the potential performance of fetal DNA as a screening marker for Down syndrome. METHODS Data on maternal serum fetal DNA concentrations and the corresponding conc...

The Potential Usefulness of Free Fetal DNA for Prenatal Gender Determination in Blood Plasma Pregnant Goat